Banner for leaf pages 2

Doripenem

Also known as Doribax

Doripenem (common name doripenem monohydrate) is an ultra-broad spectrum injectable antibiotic. It is a beta-lactam and belongs to the subgroup of carbapenems. It was launched by Shionogi Co. of Japan under the brand name Finibax in 2005 and is being marketed outside Japan by Johnson & Johnson. It is particularly active against Pseudomonas aeruginosa.

Source: Wikipedia

Estimated Total Cost: $786.06 for an average of 7 days supply

What is it prescribed for?

Patients are most commonly prescribed doripenem to treat blastomycosis, rabies, west nile virus, and pick disease.

What drug interactions are known?

Do not take doripenem if you are taking any of the following:

Critical Interactions

Significant Interactions


Ajax-loader Loading...